Bolli will lead worldwide business development for the company’s Contract Development and Manufacturing Organisation (CDMO) services
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Bidding window open till May 15; study to map costs and bottlenecks across pharma supply chains
The collaboration combines Alveus’ expertise in metabolic biology and therapeutic strategy with Aurigene’s integrated discovery capabilities
The hospital said the new centre will improve access to specialised interventions such as Deep Brain Stimulation
The goal is to better support drug developers as programs move from laboratory research into clinical trials
The programme features headline data from pivotal Phase III trials, including PREVAIL in gMG, KOMET in NF1-PN, and CHAMPION-NMOSD, alongside real-world evidence supporting established therapies
The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
New digital health companion uses friendly, jargon-free communication to help users better understand reports
Subscribe To Our Newsletter & Stay Updated
